152 related articles for article (PubMed ID: 35986249)
21. Are academic hospitals better at treating metastatic colorectal cancer?
Atallah C; Oduyale O; Stem M; Eltahir A; Almaazmi HH; Efron JE; Safar B
Surgery; 2021 Feb; 169(2):248-256. PubMed ID: 32680747
[TBL] [Abstract][Full Text] [Related]
22. High- versus low-dose leucovorin in the modified FOLFOX6 regimen for first-line treatment of metastatic colorectal cancer.
Reynolds J; Chamberland-Tremblay A; Herrington JD; Munoz Maldonado Y; Wong L
J Oncol Pharm Pract; 2017 Apr; 23(3):173-178. PubMed ID: 26786027
[TBL] [Abstract][Full Text] [Related]
23. Association Between Use of Anticancer Drugs and Cardiovascular Disease-Related Hospitalization in Metastatic Colorectal Cancer: Insights From a Population-Based Study, the Anticancer Vigilance of Cardiac Events Study.
Dolladille C; Launoy G; Bouvier V; Salem JE; Legallois D; Milliez P; Sassier M; Lobbedez T; Guittet L; Alexandre J
Am J Epidemiol; 2021 Feb; 190(3):376-385. PubMed ID: 32964219
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of primary tumour resection in synchronous metastatic colorectal cancer: Individual patient data analysis of first-line randomised trials from the ARCAD database.
van Rooijen KL; Shi Q; Goey KKH; Meyers J; Heinemann V; Diaz-Rubio E; Aranda E; Falcone A; Green E; de Gramont A; Sargent DJ; Punt CJA; Koopman M
Eur J Cancer; 2018 Mar; 91():99-106. PubMed ID: 29353165
[TBL] [Abstract][Full Text] [Related]
25. Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
Michl M; Thurmaier J; Schubert-Fritschle G; Wiedemann M; Laubender RP; Nüssler NC; Ruppert R; Kleeff J; Schepp W; Reuter C; Löhe F; Karthaus M; Neumann J; Kirchner T; Engel J; Heinemann V
Clin Colorectal Cancer; 2015 Dec; 14(4):281-90. PubMed ID: 26123495
[TBL] [Abstract][Full Text] [Related]
26. Time trends in treatment patterns and survival of older patients with synchronous metastatic colorectal cancer in the Netherlands: A population-based study.
Baltussen JC; de Glas NA; Liefers GJ; Slingerland M; Speetjens FM; van den Bos F; Cloos-van Balen M; Verschoor AJ; Jochems A; Spierings LEAMM; Holterhues C; van Gerven LA; Mooijaart SP; Portielje JEA; Derks MGM
Int J Cancer; 2023 May; 152(10):2043-2051. PubMed ID: 36620951
[TBL] [Abstract][Full Text] [Related]
27. Survival and prognostic association in stage IV colorectal cancer patients treated with chemotherapy in Bangladesh.
Shuayb M; Mehedi Hasan M; Hoque MR; Mushtaq Hussain Q; Begum R; Reza MS
Jpn J Clin Oncol; 2021 Apr; 51(4):552-559. PubMed ID: 33341898
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of First-Line Bevacizumab in Metastatic Colorectal Cancer: The Observational Cohort Study GRETA.
Franchi M; Barni S; Tagliabue G; Ricci P; Mazzucco W; Tumino R; Caputo A; Corrao G;
Oncologist; 2019 Mar; 24(3):358-365. PubMed ID: 30097524
[TBL] [Abstract][Full Text] [Related]
29. Regional and inter-hospital differences in the utilisation of liver surgery for patients with synchronous colorectal liver metastases in the Netherlands.
't Lam-Boer J; van der Stok EP; Huiskens J; Verhoeven RH; Punt CJ; Elferink MA; de Wilt JH; Verhoef C;
Eur J Cancer; 2017 Jan; 71():109-116. PubMed ID: 27988444
[TBL] [Abstract][Full Text] [Related]
30. Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience.
Jin Z; Sanhueza CT; Johnson B; Nagorney DM; Larson DW; Mara KC; Harmsen WC; Smyrk TC; Grothey A; Hubbard JM
Oncologist; 2018 Sep; 23(9):1083-1091. PubMed ID: 29674439
[TBL] [Abstract][Full Text] [Related]
31. Local ablation or radioembolization of colorectal cancer metastases: comorbidities or older age do not affect overall survival.
Seidensticker R; Damm R; Enge J; Seidensticker M; Mohnike K; Pech M; Hass P; Amthauer H; Ricke J
BMC Cancer; 2018 Sep; 18(1):882. PubMed ID: 30200921
[TBL] [Abstract][Full Text] [Related]
32. Significant increase of synchronous disease in first-line metastatic colorectal cancer trials: Results of a systematic review.
Goey KK; 't Lam-Boer J; de Wilt JH; Punt CJ; van Oijen MG; Koopman M
Eur J Cancer; 2016 Dec; 69():166-177. PubMed ID: 27821320
[TBL] [Abstract][Full Text] [Related]
33. Survival of patients with colorectal peritoneal metastases is affected by treatment disparities among hospitals of diagnosis: A nationwide population-based study.
Rovers KP; Simkens GA; Vissers PA; Lemmens VE; Verwaal VJ; Bremers AJ; Wiezer MJ; Burger JW; Hemmer PH; Boot H; van Grevenstein WM; Meijerink WJ; Aalbers AG; Punt CJ; Tanis PJ; de Hingh IH;
Eur J Cancer; 2017 Apr; 75():132-140. PubMed ID: 28222307
[TBL] [Abstract][Full Text] [Related]
34. How are elderly patients treated after a diagnosis of metastatic colorectal cancer in real-life practice? A study in a French teaching hospital.
Gouverneur A; Rouyer M; Grelaud A; Robinson P; Colombani F; Terrebonne E; Smith D; Fourrier-Réglat A; Noize P
Fundam Clin Pharmacol; 2017 Feb; 31(1):104-109. PubMed ID: 27600062
[TBL] [Abstract][Full Text] [Related]
35. Surgical volume and long-term survival following surgery for colorectal cancer in the Veterans Affairs Health-Care System.
Rabeneck L; Davila JA; Thompson M; El-Serag HB
Am J Gastroenterol; 2004 Apr; 99(4):668-75. PubMed ID: 15089900
[TBL] [Abstract][Full Text] [Related]
36. Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location.
Golan T; Urban D; Berger R; Lawrence YR
Cancer; 2013 Aug; 119(16):3084-91. PubMed ID: 23720150
[TBL] [Abstract][Full Text] [Related]
37. A real-world, population-based study of the outcomes of patients with metastatic colorectal cancer to the peritoneum treated with or without cytoreductive surgery.
Abdel-Rahman O
Int J Colorectal Dis; 2020 Apr; 35(4):719-725. PubMed ID: 32060606
[TBL] [Abstract][Full Text] [Related]
38. Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancer.
Shah MS; Fogelman DR; Raghav KP; Heymach JV; Tran HT; Jiang ZQ; Kopetz S; Daniel CR
Cancer; 2015 Sep; 121(17):2968-75. PubMed ID: 25975416
[TBL] [Abstract][Full Text] [Related]
39. An Analysis of Relationship Between RAS Mutations and Prognosis of Primary Tumour Resection for Metastatic Colorectal Cancer Patients.
Liang L; Tian J; Yu Y; Wang Z; Peng K; Liu R; Wang Y; Xu X; Li H; Zhuang R; Cui Y; Zhu C; Liu T
Cell Physiol Biochem; 2018; 50(2):768-782. PubMed ID: 30308491
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of Access to Hospitals Most Ready to Achieve National Accreditation for Rectal Cancer Treatment.
Antunez AG; Kanters AE; Regenbogen SE
JAMA Surg; 2019 Jun; 154(6):516-523. PubMed ID: 30785616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
